Albucid is used for infectious eye diseases caused by microorganisms sensitive to sulfonamides.
Active ingredient: Sodium sulfacetamide 200 mg/ml.
Excipients: Polyvinyl alcohol 1.4%; Sodium thiosulfate 1.5 mg/ml; Monobasic sodium phosphate 1.56 mg/ml; Dibasic sodium phosphate 0.71 mg/ml; Disodium edetate 0.01 mg/ml; Benzalkonium chloride 0.005%; Water for injection.
Albucid is indicated for infectious eye diseases caused by microorganisms sensitive to sulfonamides, including:
Conjunctivitis
Blepharitis
Purulent corneal ulcers
As part of complex treatment of trachoma
Toxic or allergic reactions to sulfonamides.
Use during pregnancy and breastfeeding:
Use if clearly needed and under medical supervision.
Local irritation
Burning sensation
Non-specific conjunctivitis
Conjunctival hyperemia
Instill 1–2 drops into the conjunctival sac every 2–3 hours.
Treatment course: 7–10 days.
In trachoma: 2 drops every 2 hours.
In case of overdose, reduce the dosage, increase the intervals between applications, or discontinue use.
Reduces bacteriostatic effect when used with novocaine or dicaine.
Incompatible with silver salts.
Patients with hypersensitivity to furosemide, thiazide diuretics, sulfonylureas, or carbonic anhydrase inhibitors may also be hypersensitive to sulfacetamide.
Prolonged use may lead to increased growth of resistant microorganisms, including fungi.
2 years
Store at 8–25°C